Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alexandre, Perani"'
Autor:
Maxime Roubinet, David Rizzo, Jasmine Chauzeix, Pascal Turlure, Marie-Pierre Laforet, Paco Derouault, Jean Feuillard, Catherine Yardin, Marie-Mathilde Auboiroux, Léa Veyrune, Alexandre Perani, Sylvie Bourthoumieu, Benjamin Dauriat, Nathalie Gachard
Publikováno v:
HemaSphere, Vol 7, p e173837c (2023)
Externí odkaz:
https://doaj.org/article/ab20469eedcf4af7a3aa8b0a18b13828
Autor:
Alexandre Perani, Sylvie Bourthoumieu, David Rizzo, Jasmine Chauzeix, Benjamin Dauriat, Pascal Turlure, Stéphane Girault, Léa Veyrune, Maxime Roubinet, Jean Feuillard, Catherine Yardin, Nathalie Gachard
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundPredisposition to myeloid malignancies is a field at the border of hematology and genetics. Knowledge in this domain has so rapidly increased that WHO defined in 2016 the new “Myeloid Neoplasms with Germline Predisposition” category of
Externí odkaz:
https://doaj.org/article/2983c16b234649e8be5f75d4c94ad043
Autor:
Sandra Pinet, Stéphanie Durand, Alexandre Perani, Léa Darnaud, Fifame Amadjikpe, Mathieu Yon, Tiffany Darbas, Alain Vergnenegre, Thomas Egenod, Yannick Simonneau, Valérie Le Brun-Ly, Julia Pestre, Laurence Venat, Frédéric Thuillier, Alain Chaunavel, Mathilde Duchesne, Véronique Fermeaux, Anne Guyot, Sylvain Lacorre, Barbara Bessette, Fabrice Lalloué, Karine Durand, Elise Deluche
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundIn the context of personalized medicine, screening patients to identify targetable molecular alterations is essential for therapeutic decisions such as inclusion in clinical trials, early access to therapies, or compassionate treatment. The
Externí odkaz:
https://doaj.org/article/38353bee4b534532bc7e1714a16257c9
Autor:
Ioanna Pyromali, Alexandre Perani, Angélique Nizou, Nesrine Benslimane, Paco Derouault, Sylvie Bourthoumieu, Mélanie Fradin, Guilhem Sole, Fanny Duval, Constantin Gomes, Frédéric Favreau, Franck Sturtz, Corinne Magdelaine, Anne-Sophie Lia
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 19, Iss , Pp 4265-4272 (2021)
Next-generation sequencing (NGS) allows the detection of mutations in inherited genetic diseases, like the Charcot-Marie-Tooth disease (CMT) which is the most common hereditary peripheral neuropathy. The majority of mutations detected by NGS are sing
Externí odkaz:
https://doaj.org/article/7e358b27452f44e59045c62065768904